Belmont Medical Technologies Receives $221K in Training Grant via via the Commonwealth of Massachusetts’ Workforce Training Fund Program
Belmont Medical Technologies currently employs 187 associates, including 137 in Massachusetts.
4WEB Medical Receives 510(k) Clearance to Market Their Lumbar Plating Solution
New product launch bolsters lateral portfolio and sets the company up for significant growth in 2021.
Intellis Platform with DTM Spinal Cord Stimulation Receives FDA Revised Commercial Labelling
Intellis™ Platform with Differential Target Multiplexed (DTM™) programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting superior back pain relief with DTM SCS when compared to conventional SCS.
VisCardia Announces Issuance of American Medical Association CPT® Category III Codes for Synchronized Diaphragmatic Stimulation
VisCardia notes the CPT Category III codes for SDS will be effective Jan. 1, 2022, and provide the ability to track the VisONE implant and related procedures moving forward, including during VisCardia's anticipated US IDE study.
NovaSight Announces First-Ever Pivotal Study for Lazy-Eye Digital Treatment Against Gold Standard Patching
NovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).